Literature DB >> 1378918

Myeloblastoma formation in acute myeloid leukemia.

Y Iizuka1, M Aiso, K Oshimi, M Kanemaru, M Kawamura, J Takeuchi, A Horikoshi, T Ohshima, H Mizoguchi, T Horie.   

Abstract

The cell surface markers on the leukemic cells of 76 patients with adult acute myeloid leukemia (AML) have been analyzed by indirect immunofluorescence, and the presence of CD56+ leukemic cells was detected in ten of these patients. Four of these 10 CD56+ AML patients developed extramedullary myeloblastomas and in two of them an intracranial myeloblastoma. In contrast, in the remaining 66 CD56- AML patients, only one patient developed a myeloblastoma formation of the subcutaneous. It may be that the CD56 antigen which is an isoform of the neural cell adhesion molecule (NCAM), expressed on neurons, satellite cells of skeletal muscle cells, and on stromal cells, binds these tissues by a homophilic mechanism. CD56+ leukemic cells are capable of invading and of surviving in extramedullary tissues, where they proliferate and develop into a myeloblastoma. Because of this possibility, CD56+ AML patients should be carefully monitored for signs of myeloblastoma formation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1378918     DOI: 10.1016/0145-2126(92)90017-2

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  8 in total

1.  Acute myeloid leukemia (FAB-M2) with a masked type of t(8;21) translocation revealed by spectral karyotyping.

Authors:  Jun-ichi Miyagi; Naoki Kakazu; Masato Masuda; Takashi Miyagi; Tamiko Toyohama; Tetsuro Nakazato; Takeaki Tomoyose; Tetsuharu Shinjyo; Akitoshi Nagasaki; Naoya Taira; Misao Ohki; Tatsuo Abe; Nobuyuki Takasu
Journal:  Int J Hematol       Date:  2002-11       Impact factor: 2.490

2.  Acute myeloid leukemia with mediastinal myeloid sarcoma refractory to acute myeloid leukemia therapy but responsive to L-asparaginase.

Authors:  Hiroyoshi Takahashi; Katsuyoshi Koh; Motohiro Kato; Hiroshi Kishimoto; Eiji Oguma; Ryoji Hanada
Journal:  Int J Hematol       Date:  2012-05-29       Impact factor: 2.490

3.  Factors associated with risk of central nervous system relapse in patients with non-core binding factor acute myeloid leukemia.

Authors:  Elias Jabbour; Naval Guastad Daver; Nicholas James Short; Xuelin Huang; Hsiang-Chun Chen; Abhishek Maiti; Farhad Ravandi; Jorge Cortes; Simon Abi Aad; Guillermo Garcia-Manero; Zeev Estrov; Tapan Kadia; Susan O'Brien; Bouthaina Dabaja; Carlos Bueso-Ramos; Paolo Strati; Carol Bivins; Sherry Pierce; Hagop Kantarjian
Journal:  Am J Hematol       Date:  2017-07-19       Impact factor: 10.047

4.  Isolated recurrence of acute myeloid leukemia in the cerebellum: illustrative case.

Authors:  Vikraant Kohli; Michael T Koltz; Ashwin A Kamath
Journal:  J Neurosurg Case Lessons       Date:  2021-08-23

5.  Prognostic significance of CD7+CD56+ phenotype and chromosome 5 abnormalities for acute myeloid leukemia M0.

Authors:  Ritsuro Suzuki; Makoto Murata; Masahiro Kami; Shigeki Ohtake; Norio Asou; Yoshihisa Kodera; Masao Tomonaga; Yasufumi Masaki; Shuya Kusumoto; Jin Takeuchi; Shin Matsuda; Hisamaru Hirai; m Seiichi Yorimitsu; Nobuyuki Hamajima; Masao Seto; Masanori Shimoyama; Ryuzo Ohno; Yasuo Morishima; Shigeo Nakamura
Journal:  Int J Hematol       Date:  2003-06       Impact factor: 2.490

6.  Granulocytic sarcoma of the prostate as the first manifestation of a late relapse of acute myelogenous leukemia.

Authors:  F Thalhammer; H Gisslinger; A Chott; O Haas; A Etele-Hainz; T Helbich; R Kusec; W Linkesch; I Simonitsch; H Strobl
Journal:  Ann Hematol       Date:  1994-02       Impact factor: 3.673

7.  Ocular manifestation in myeloid/NK cell precursor acute leukemia: a case report. Diagnosed by flow cytometry and PCR from aqueous humor.

Authors:  Sayaka Akaike; Koju Kamoi; Mari Tezuka; Daisuke Tomizawa; Ryoichi Yoshimura; Masatoshi Takagi; Kyoko Ohno-Matsui
Journal:  Medicine (Baltimore)       Date:  2016-09       Impact factor: 1.889

8.  Clinical Courses of Two Pediatric Patients with Acute Megakaryoblastic Leukemia Harboring the CBFA2T3-GLIS2 Fusion Gene.

Authors:  Mayu Ishibashi; Tomoko Yokosuka; Masakatsu D Yanagimachi; Fuminori Iwasaki; Shin-Ichi Tsujimoto; Koji Sasaki; Masanobu Takeuchi; Reo Tanoshima; Hiromi Kato; Ryosuke Kajiwara; Fumiko Tanaka; Hiroaki Goto; Shumpei Yokota
Journal:  Turk J Haematol       Date:  2016-04-18       Impact factor: 1.831

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.